These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10092130)

  • 21. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.
    Schmidt EE; Ichimura K; Goike HM; Moshref A; Liu L; Collins VP
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1170-83. PubMed ID: 10560660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
    Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma.
    Yeh KT; Chang JG; Chen YJ; Chen ST; Yu SY; Shih MC; Perng LI; Wang JC; Tsai M; Chang CP
    Cancer Invest; 2000; 18(2):123-9. PubMed ID: 10705874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and molecular analyses of 10q deletions in human gliomas.
    Steck PA; Lin H; Langford LA; Jasser SA; Koul D; Yung WK; Pershouse MA
    Genes Chromosomes Cancer; 1999 Feb; 24(2):135-43. PubMed ID: 9885980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
    Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
    Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
    Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
    Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies.
    Dahia PL; Aguiar RC; Alberta J; Kum JB; Caron S; Sill H; Marsh DJ; Ritz J; Freedman A; Stiles C; Eng C
    Hum Mol Genet; 1999 Feb; 8(2):185-93. PubMed ID: 9931326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coincidental LOH regions in mouse and humans: evidence for novel tumor suppressor loci at 9q22-q34 in non-Hodgkin's lymphomas.
    Meléndez B; Cuadros M; Robledo M; Rivas C; Fernández-Piqueras J; Martínez-Delgado B; Benítez J
    Leuk Res; 2003 Jul; 27(7):627-33. PubMed ID: 12681362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
    Tashiro H; Blazes MS; Wu R; Cho KR; Bose S; Wang SI; Li J; Parsons R; Ellenson LH
    Cancer Res; 1997 Sep; 57(18):3935-40. PubMed ID: 9307275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
    Vlietstra RJ; van Alewijk DC; Hermans KG; van Steenbrugge GJ; Trapman J
    Cancer Res; 1998 Jul; 58(13):2720-3. PubMed ID: 9661880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.
    Sasaki H; Zlatescu MC; Betensky RA; Ino Y; Cairncross JG; Louis DN
    Am J Pathol; 2001 Jul; 159(1):359-67. PubMed ID: 11438483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infrequent genetic alterations of the PTEN gene in Japanese patients with sporadic prostate cancer.
    Orikasa K; Fukushige S; Hoshi S; Orikasa S; Kondo K; Miyoshi Y; Kubota Y; Horii A
    J Hum Genet; 1998; 43(4):228-30. PubMed ID: 9852672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.
    Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
    Anticancer Res; 1999; 19(5B):3841-6. PubMed ID: 10628321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
    Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
    Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
    Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
    Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.
    Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C
    Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
    Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
    Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of deletions of the PTEN/MMAC1 and MXI1 loci in renal cell carcinoma by interphase cytogenetics.
    Gesk S; Siebert R; Wacker HH; Nürnberg N; Harder L; Lehman J; Klöppel G; Grote W; Stöckle M; Schlegelberger B
    Cancer Genet Cytogenet; 2000 Apr; 118(1):87-8. PubMed ID: 10766523
    [No Abstract]   [Full Text] [Related]  

  • 39. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
    Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
    Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
    Li J; Yen C; Liaw D; Podsypanina K; Bose S; Wang SI; Puc J; Miliaresis C; Rodgers L; McCombie R; Bigner SH; Giovanella BC; Ittmann M; Tycko B; Hibshoosh H; Wigler MH; Parsons R
    Science; 1997 Mar; 275(5308):1943-7. PubMed ID: 9072974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.